Single and Repeated Doses of EGb 761(®) do not Affect Pharmacokinetics or Pharmacodynamics of Rivaroxaban in Healthy Subjects

The present drug-drug interaction study investigates whether single or repeated doses of 240 mg Ginkgo biloba extract EGb 761(®) alter the pharmacokinetics or pharmacodynamics of rivaroxaban in healthy subjects. This was a single-centre, two-period, fixed-sequence trial. In Period 1, rivaroxaban was...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoerr, Robert, Zimmermann, Andrea, Seitz, Friedeborg, Dienel, Angelika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065292/
https://www.ncbi.nlm.nih.gov/pubmed/35517810
http://dx.doi.org/10.3389/fphar.2022.868843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065292/
https://www.ncbi.nlm.nih.gov/pubmed/35517810
http://dx.doi.org/10.3389/fphar.2022.868843

Ejemplares similares